Brokers Issue Forecasts for SurgePays, Inc.'s Q1 2024 Earnings (NASDAQ:SURG)

→ Gold Mania (From Stansberry Research) (Ad)

SurgePays, Inc. (NASDAQ:SURG - Free Report) - Equities research analysts at Sidoti Csr issued their Q1 2024 EPS estimates for SurgePays in a research report issued on Tuesday, April 23rd. Sidoti Csr analyst A. Soderstrom expects that the medical equipment provider will earn $0.27 per share for the quarter. Sidoti Csr also issued estimates for SurgePays' Q2 2024 earnings at $0.00 EPS, Q3 2024 earnings at $0.05 EPS, Q4 2024 earnings at $0.09 EPS, FY2024 earnings at $0.42 EPS, Q1 2025 earnings at $0.13 EPS, Q2 2025 earnings at $0.14 EPS, Q3 2025 earnings at $0.16 EPS, Q4 2025 earnings at $0.17 EPS and FY2025 earnings at $0.61 EPS.

SurgePays (NASDAQ:SURG - Get Free Report) last issued its earnings results on Tuesday, March 12th. The medical equipment provider reported $0.19 EPS for the quarter. SurgePays had a net margin of 15.03% and a return on equity of 104.66%. The firm had revenue of $32.32 million during the quarter.

Several other equities research analysts also recently commented on the stock. Maxim Group downgraded shares of SurgePays from a "buy" rating to a "hold" rating in a research note on Wednesday, March 13th. Ascendiant Capital Markets lowered their price objective on shares of SurgePays from $11.50 to $10.00 and set a "buy" rating for the company in a research report on Monday, April 1st.


View Our Latest Analysis on SURG

SurgePays Trading Up 0.9 %

NASDAQ:SURG traded up $0.03 during trading hours on Thursday, hitting $3.36. The stock had a trading volume of 119,205 shares, compared to its average volume of 744,569. SurgePays has a one year low of $3.28 and a one year high of $9.23. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.91 and a current ratio of 2.63. The company has a market cap of $64.81 million, a price-to-earnings ratio of 2.42 and a beta of 1.08. The business's 50 day moving average is $5.13 and its 200-day moving average is $5.76.

Institutional Investors Weigh In On SurgePays

Several large investors have recently made changes to their positions in SURG. James Investment Research Inc. bought a new position in SurgePays in the third quarter valued at $47,000. Oxford Asset Management LLP bought a new position in SurgePays in the fourth quarter valued at $71,000. FNY Investment Advisers LLC bought a new position in SurgePays in the fourth quarter valued at $95,000. Jump Financial LLC lifted its stake in SurgePays by 44.7% in the fourth quarter. Jump Financial LLC now owns 16,500 shares of the medical equipment provider's stock valued at $106,000 after acquiring an additional 5,100 shares during the last quarter. Finally, Victory Capital Management Inc. acquired a new stake in SurgePays in the fourth quarter valued at $106,000. Institutional investors own 6.94% of the company's stock.

SurgePays Company Profile

(Get Free Report)

SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.

Further Reading

Earnings History and Estimates for SurgePays (NASDAQ:SURG)

→ FW: 234x Gain (From Weiss Ratings) (Ad)

Should you invest $1,000 in SurgePays right now?

Before you consider SurgePays, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SurgePays wasn't on the list.

While SurgePays currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: